Combined effect of Intraoperative drugs Milrinone- Terlipressin on blood loss during hepatic resection.
Not Applicable
Completed
- Conditions
- Health Condition 1: C228- Malignant neoplasm of liver, primary, unspecified as to typeHealth Condition 2: O- Medical and Surgical
- Registration Number
- CTRI/2022/11/047220
- Lead Sponsor
- PGIMER
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 36
Inclusion Criteria
ASA physical status I/II
Patients posted for major or minor elective hepatic resection.
Exclusion Criteria
1. Patients with portal hypertension
2. Patients with symptomatic CAD, valvular heart disease and Hypertension ( >160/90 despite two anti-hypertensives)
3. Pre-existing severe hepatic or renal insufficiency ( Child Pugh B or C, GFR < 60)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood loss during hepatic resection.Timepoint: After completion of hepatic resection
- Secondary Outcome Measures
Name Time Method